Attached files

file filename
10-Q - BRAINSTORM CELL THERAPEUTICS INC.v222233_10q.htm
EX-31.2 - BRAINSTORM CELL THERAPEUTICS INC.v222233_ex31-2.htm
EX-32.2 - BRAINSTORM CELL THERAPEUTICS INC.v222233_ex32-2.htm
EX-31.1 - BRAINSTORM CELL THERAPEUTICS INC.v222233_ex31-1.htm
EXHIBIT 32.1
 
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

In connection with the accompanying Quarterly Report on Form 10-Q of Brainstorm Cell Therapeutics Inc. for the period ended March 31, 2011, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:

(1) such Quarterly Report on Form 10-Q for the period ended March 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2011 fairly presents, in all material respects, the financial condition and results of operations.

May 13, 2011
/s/ Adrian Harel
 
Name: Adrian Harel
 
Title: Acting Chief Executive Officer (Principal Executive Officer)